T
Tom P. Theruvath
Researcher at Medical University of South Carolina
Publications - 55
Citations - 3807
Tom P. Theruvath is an academic researcher from Medical University of South Carolina. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 27, co-authored 55 publications receiving 3599 citations. Previous affiliations of Tom P. Theruvath include Humboldt University of Berlin & Humboldt State University.
Papers
More filters
Journal ArticleDOI
Strategies to improve long-term outcomes after renal transplantation.
TL;DR: Current antirejection therapy, including calcineurin blockers such as cyclosporine and tacrolimus, the interleukin-2 signal-transduction inhibitor sirolimus and the purine-synthesis inhibitor mycophenolate mofetil are discussed, which inhibits the proliferation of T cells and B cells.
Journal ArticleDOI
Mitochondrial calcium and the permeability transition in cell death.
TL;DR: The exact role of Ca(2+) for inducing the mitochondrial permeability transition and cell death depends on the particular biologic setting.
Journal ArticleDOI
Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.
Nada Rayes,Daniel Seehofer,Tom P. Theruvath,Reinhold Schiller,Jan M. Langrehr,Sven Jonas,Stig Bengmark,Peter Neuhaus +7 more
TL;DR: The aim is to study if a combination of different LAB and fibers would further improve outcome, which recently reported significant progress with a synbiotic composition, consisting of one lactic acid bacteria and one fiber.
Journal ArticleDOI
Effect of Enteral Nutrition and Synbiotics on Bacterial Infection Rates After Pylorus-preserving Pancreatoduodenectomy: A Randomized, Double-blind Trial
Nada Rayes,Daniel Seehofer,Tom P. Theruvath,Martina T. Mogl,Jan M. Langrehr,Natascha C. Nüssler,Stig Bengmark,Peter Neuhaus +7 more
TL;DR: Early enteral nutrition supplemented with a mixture of LAB and fibers reduces bacterial infection rates and antibiotic therapy following PPPD.
Journal ArticleDOI
Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
Tom P. Theruvath,Susan L. Saidman,Shamila Mauiyyedi,Francis L. Delmonico,Winfred W. Williams,Nina Tolkoff-Rubin,A. Bernard Collins,Robert B. Colvin,A. Benedict Cosimi,Manuel Pascual +9 more
TL;DR: It is suggested that a decrease in DSA production can be induced in renal allograft recipients with 'chronic humoral rejection' by using an immunosuppressive regimen that combines tacrolimus and mycophenolate mofetil.